Merrill Lynch Upgrades PharMerica (PMC) to Buy
More News related to PMC
- PharMerica to Present at the Credit Suisse 18th Annual Healthcare Conference
- PharMerica to Present at the Oppenheimer 20th Annual Healthcare Conference
- PharMerica (PMC) Tops Q3 EPS by 16c; Guides In-Line
- PharMerica Reports Results for the Third Quarter of 2009 and Nine Months Ended September 30, 2009
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
More News related to Upgrades
- Credit Suisse Raises Rating on European Equities from Underweight to Overweight
- Canaccord Adams Upgrades Pan American Silver (PAAS) to Buy
- National Bank Upgrades Pengrowth Energy (PGH) to Outperform
- Ardour Capital Upgrades Capstone Turbine (CPST) to Accumulate
- Global Hunter Securities Upgrades Petroleum Development Corp. (PETD) to Buy
Merrill Lynch upgrades PharMerica (NYSE: PMC) from Neutral to Buy.
PharMerica Corporation is an institutional pharmacy services company.
Related Categories
UpgradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
